Search research articles
Contact Us
Filters
Showing results (1-10 of 289) with videos related to
Page
of 29
Sort By:
Clinical Trials (London, England)
|
March 17, 2006
The continual reassessment method for dose-finding studies: a tutorial
Elizabeth Garrett-Mayer
Cancer
|
December 25, 2019
Geographically distributed data should be analyzed with spatial epidemiologic methods
Elizabeth Garrett-Mayer
Journal of Child Psychology and Psychiatry, and Allied Disciplines
|
May 23, 2006
Development in infants with autism spectrum disorders: a prospective study
Rebecca Landa, Elizabeth Garrett-Mayer
Clinical Trials (London, England)
|
July 5, 2025
Sixteenth Annual University of Pennsylvania conference on statistical issues in clinical trial/optimizing dose-finding across the clinical trials spectrum (morning panel discussion)
Ken Cheung, Elizabeth Garrett-Mayer
The Lancet. Oncology
|
November 27, 2025
Of surrogate endpoints, shortcuts, and safety
Clifford A Hudis, Elizabeth Garrett-Mayer
JAMA Oncology
|
October 29, 2020
To Treat or Not to Treat-Balancing Benefits and Risks of Treatment Delay Among Patients With Cancer During the COVID-19 Pandemic
Elizabeth Garrett-Mayer, Brian I Rini
Statistics in Biopharmaceutical Research
|
December 8, 2018
An adaptive dose-finding design based on both safety and immunologic responses in cancer clinical trials
Cody Chiuzan, Elizabeth Garrett-Mayer, Michael Nishimura
The Lancet. Oncology
|
May 31, 2026
The global cancer workforce crisis: a shared responsibility, a united front
Julie R Gralow, Douglas Pyle, Elizabeth Garrett-Mayer
Plos Medicine
|
March 29, 2007
How should treatment decisions be made for incapacitated patients, and why?
David I Shalowitz, Elizabeth Garrett-Mayer, David Wendler
Archives of Internal Medicine
|
March 15, 2006
The accuracy of surrogate decision makers: a systematic review
David I Shalowitz, Elizabeth Garrett-Mayer, David Wendler
Page
of 29
Search research articles
Search
Showing results (1-10 of 289) with videos related to
Sort By:
Page
of 29
Clinical Trials (London, England)
|
March 17, 2006
The continual reassessment method for dose-finding studies: a tutorial
Elizabeth Garrett-Mayer
Cancer
|
December 25, 2019
Geographically distributed data should be analyzed with spatial epidemiologic methods
Elizabeth Garrett-Mayer
Journal of Child Psychology and Psychiatry, and Allied Disciplines
|
May 23, 2006
Development in infants with autism spectrum disorders: a prospective study
Rebecca Landa, Elizabeth Garrett-Mayer
Clinical Trials (London, England)
|
July 5, 2025
Sixteenth Annual University of Pennsylvania conference on statistical issues in clinical trial/optimizing dose-finding across the clinical trials spectrum (morning panel discussion)
Ken Cheung, Elizabeth Garrett-Mayer
The Lancet. Oncology
|
November 27, 2025
Of surrogate endpoints, shortcuts, and safety
Clifford A Hudis, Elizabeth Garrett-Mayer
JAMA Oncology
|
October 29, 2020
To Treat or Not to Treat-Balancing Benefits and Risks of Treatment Delay Among Patients With Cancer During the COVID-19 Pandemic
Elizabeth Garrett-Mayer, Brian I Rini
Statistics in Biopharmaceutical Research
|
December 8, 2018
An adaptive dose-finding design based on both safety and immunologic responses in cancer clinical trials
Cody Chiuzan, Elizabeth Garrett-Mayer, Michael Nishimura
The Lancet. Oncology
|
May 31, 2026
The global cancer workforce crisis: a shared responsibility, a united front
Julie R Gralow, Douglas Pyle, Elizabeth Garrett-Mayer
Plos Medicine
|
March 29, 2007
How should treatment decisions be made for incapacitated patients, and why?
David I Shalowitz, Elizabeth Garrett-Mayer, David Wendler
Archives of Internal Medicine
|
March 15, 2006
The accuracy of surrogate decision makers: a systematic review
David I Shalowitz, Elizabeth Garrett-Mayer, David Wendler
Page
of 29